NovAccess Global Inc.: NovAccess Global Appoints Healthcare IP Consultant Dr. Peter Weinstein to Scientific Advisory Board
CLEVELAND, OH / ACCESSWIRE / November 10, 2022 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing novel immunotherapies for brain tumor patients, today announced the appointment of Peter
United States National Institutes Of Health San Diego Phleger Harrison Peter Weinstein Peterd Weinstein
Source: finanznachrichten.de